Reprieve system study for hospitalized heart failure
Part of Heart & circulation clinical trials.
This study tests a device (Reprieve System) to remove extra fluid more safely in heart failure patients while they are hospitalized. It may be a good option if you have fluid buildup and are not too sick from other conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently in the hospital for heart failure, with symptoms like shortness of breath or swelling.
- You are at least 10 pounds (4.5 kg) over your normal weight (without extra fluid).
- You are 18 years or older and can understand and follow the study procedures.
- You do not have severe kidney disease (eGFR <20) or need dialysis.
- You do not have very low blood pressure or need IV medications to keep it up.
- You are not pregnant or planning to become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a device designed to safely remove extra fluid from patients hospitalized with worsening heart failure. It may help those who are not responding well to standard water pills (diuretics).
This trial studies a device (the Nephronyx System) used in the hospital to treat worsening heart failure with fluid buildup, especially when diuretics (water pills) aren’t working well. It aims to check the device’s safety and whether it performs as expected to help patients get better.
This study tests whether using ultrasound-guided treatment to reduce fluid buildup in the body can help people hospitalized for worsening heart failure feel better faster. It's for adults admitted with heart failure and high BNP levels.
This trial tests a device that briefly blocks blood flow in a large vein to help your body remove extra fluid, which may improve symptoms like swelling and shortness of breath. It is for people with advanced heart failure who are already in the hospital and need more help with fluid removal.
This trial tests whether the eLym™ device is safe and practical to use in people hospitalized for worsening heart failure with excess fluid. It may help reduce fluid overload while the team checks safety during and after the procedure.
This trial tests a wearable device that removes extra fluid from your body without using the kidneys. It may help people with heart failure who still have fluid buildup despite taking high doses of water pills.
Hear when a new Acute Decompensated Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.